Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Northern Bitcoin AG    NB2   DE000A0SMU87

NORTHERN BITCOIN AG

(NB2)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/09/2019 09/10/2019 09/11/2019 09/12/2019 09/13/2019 Date
11(c) 10.3(c) 11.4(c) 11.9(c) 13.2(c) Last
2 834 1 765 2 489 4 967 1 379 Volume
+1.85% -6.36% +10.68% +4.39% +10.92% Change
More quotes
Financials (EUR)
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
Sales 2019 -
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019 -
Capi. / Sales2018 -
Capi. / Sales2019 -
Capitalization 132 M
More Financials
Company
Biosilu Healthcare AG, formerly Amp Biosimilars AG, is a Germany-based biopharmaceutical company. The Company focuses on the development and commercialization of specialty biopharmaceuticals for patients in Asian regions. 
More about the company
Latest news on NORTHERN BITCOIN AG
09/11NORTHERN BITCOIN : Starts with own wallet app 'wallace'
EQ
09/09NORTHERN BITCOIN : Prepared to enter the market with its new mining container
EQ
07/01NORTHERN BITCOIN : Doubles its mining capacities
EQ
07/01NORTHERN BITCOIN : Acquires mining hardware
EQ
06/29NORTHERN BITCOIN : Receives financing of eur 8 million
EQ
06/24NORTHERN BITCOIN : Begins with the global scaling of its green bitcoin mining
EQ
05/28NORTHERN BITCOIN : plans extensive cooperation with one of the world's leading c..
EQ
2018NORTHERN BITCOIN AG : Dirk ströer buys large share package
EQ
2018NORTHERN BITCOIN : Agrees comprehensive strategic cooperation with rawpool - lau..
EQ
2018NORTHERN BITCOIN : And rawpool agree on comprehensive strategic cooperation in t..
EQ
More news
Sector news : Bio Therapeutic Drugs
09/13GILEAD SCIENCES : Louisiana's Deal for Hepatitis C Drugs May Serve as Model -- J..
DJ
09/13GILEAD SCIENCES : Louisiana's Deal for Hepatitis C Drugs May Serve as Model -- J..
DJ
09/03Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
RE
08/29GLOBAL MARKETS LIVE : Dell, United Airlines, UBS, Apple…
08/28U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight
RE
More sector news : Bio Therapeutic Drugs
Chart NORTHERN BITCOIN AG
Duration : Period :
Northern Bitcoin AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NORTHERN BITCOIN AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 12,90  €
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Mathis Schultz Chief Executive Officer
Stefan Elsser Chairman-Supervisory Board
Moritz F. Jäger Chief Technology Officer
Bernd Hartmann Member-Supervisory Board
Simon Jules Nebel Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
NORTHERN BITCOIN AG-28.65%147
GILEAD SCIENCES6.35%84 245
VERTEX PHARMACEUTICALS5.57%44 966
REGENERON PHARMACEUTICALS-24.60%30 815
GENMAB28.81%13 161
NEUROCRINE BIOSCIENCES, INC.35.01%8 829